Meredith Mental Health Counseling, Pllc Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 46 Pond Gut Rd, Pleasant Valley, NY 12569 Phone: 845-416-4639 |
Healthy Minds Counseling Services Lcsw Pllc Social Worker - Clinical Medicare: Medicare Enrolled Practice Location: 42 Gretna Rd, Pleasant Valley, NY 12569 Phone: 914-475-3041 |
Meredith Mental Health Counseling, Pllc Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 46 Pond Gut Rd, Pleasant Valley, NY 12569 Phone: 845-416-4639 |
Pleasant Valley Mental Health Counseling, Pllc Counselor Medicare: Not Enrolled in Medicare Practice Location: 143 Gretna Woods Rd, Pleasant Valley, NY 12569 Phone: 845-857-7283 |
Shannon Barrows Lcsw Pllc Social Worker - Clinical Medicare: Medicare Enrolled Practice Location: 1612 Main St Unit 2, Pleasant Valley, NY 12569 Phone: 845-366-9170 |
Sierra Counseling And Therapy Services Inc Social Worker - Clinical Medicare: Medicare Enrolled Practice Location: 323 Freedom Rd, Pleasant Valley, NY 12569 Phone: 914-474-1679 |
News Archive
Scleroderma is a rare and often fatal disease, causing the thickening of tissue, that currently lacks a cure and any effective treatments. A group of researchers, including a Michigan State University professor, is looking to change that.
Scientists from the Tumor Immunotherapy and Microenvironment research group led by Dr Bassam Janji at the Luxembourg Institute of Health Department of Oncology, and the Swedish pharma company Sprint Bioscience published the results of an innovative approach that turns "cold" tumors "hot". "Cold", immune-desert tumors are classically immunotherapy-resistant.
In a paper appearing in Scientific Reports today, the motion of micro-organisms as they swim through various types of fluid channels show "quite strange and new" responses for single cell organisms, including the performance of somersaults, meandering wanderings, and even a ballistic type of behavior, wrote Sunghwan "Sunny" Jung, a member of the Virginia Tech Department of Biomedical Engineering and Mechanics.
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced that a new patent has been issued by the U.S. Patent and Trademark Office (USPTO) relating to its tamper-resistant DETERxâ„¢ formulation platform. US Patent Number 7,771,707 contains claims that cover Collegium's proprietary extended-release formulations, which are designed to resist dose dumping when subjected to a variety of physical methods of tampering.
› Verified 4 days ago